profit slide india dr reddi profit indian drugmak dr reddi fell 93 research cost rose sale flag firm said profit 40m rupe 915000 486000 three month decemb sale fell 8 47bn rupe dr reddi built reput produc generic version bignam pharmaceut product competit intensifi firm compani short new product launch recent annouc decemb 2000 won exclus market right generic version famous antidepress prozac maker eli lilli also lost key court case march 2004 ban sell version pfizer popular hypertens drug norvasc us research develop new drug continu apac rd spend rise 37 705m rupe key caus decreas profit alongsid fall sale patent number wellknown product due run near futur repres opportun dr reddi whose share list new york indian generic manufactur sale dr reddi generic busi fell 86 966m rupe anoth stapl firm busi sale ingredi drug also perform poor sale 25 previous year 14bn rupe face strong competit home us europ dr reddi indian competitor gather strength although face heavi competit pressur 